Stock Performance and Trading Context
Healthcare Realty Trust (NYSE: HR) shares rise 2.7% intraday first. They hit nearly $18.00 after Q4 2025 earnings release. Next, this boosts year-to-date gains. HR stock price stays in $14-$19 range. For example, healthcare REIT recovery builds amid deleveraging. Plus, asset sales help. Yet, no upgrades or target changes happen that day.
Q4 2025 Earnings Snapshot
Healthcare Realty reports $14.4M GAAP net income, or $0.04/share. NAREIT FFO hits $127M, or $0.36/share. Normalized FFO reaches $142M, or $0.40/share. FAD totals $114M at 75% payout. Same-store NOI grows 5.5% YoY. Retention stays at 82.7%. Leasing spreads add 3.7%. So, activity thrives. Company signs 1.5M sq ft leases. New leases cover 316K sq ft. Redevelopments gain 500+ bps.
Portfolio Activity and Capital Recycling
Healthcare Realty sells $682M assets in Q4 and February. Net debt/EBITDA drops to 5.4x. It repays $542M term loans. Liquidity hits $1.4B. Moody’s affirms Baa2 rating. Outlook turns Stable.
Full-Year 2025 Results
Healthcare Realty posts $(246M) GAAP loss, or $(0.71)/share for FY2025. NAREIT FFO totals $490M, or $1.38/share. Normalized FFO reaches $569M, or $1.61/share. FAD is $448M at 87% payout. Same-store NOI rises 4.8%. Occupancy gains 103 bps. Retention hits 81.5%. Spreads average 3.1%. Leasing totals 5.8M sq ft. New leases: 1.6M sq ft.
Dispositions, Debt, and Corporate Actions
Company disposes $1.2B across 34 deals at 6.7% cap rate. Leverage falls to 5.4x from 6.1x. It repays $650M loans and $250M notes.
Dividend and 2026 Guidance
Board sets $0.24/share dividend. It pays March 11, 2026. 2026 guidance: EPS $(0.05)-$0.05. NAREIT FFO $1.44-$1.50/share. Normalized FFO $1.58-$1.64/share. NOI growth 3.5%-4.5%.
Balance Sheet and Portfolio Scale
REIT owns 562 properties, 32.7M sq ft in 27 states. Enterprise value: $10.1B.
Key Q4 vs FY2025 Metrics
Metric
Q4 2025
FY 2025
GAAP Net Income (EPS)
$14.4M ($0.04)
$(246M) ($(0.71))
NAREIT FFO/Share
$0.36
$1.38
Normalized FFO/Share
$0.40
$1.61
Same-Store NOI Growth
5.5%
4.8%
Asset Sales
$682M
$1.2B
